Transcriptome-wide association studies (TWAS), an integrative framework using expression quantitative trait loci (eQTLs) to construct proxies for gene expression, have emerged as a promising method to investigate the biological mechanisms underlying associations between genotypes and complex traits. However, challenges remain in interpreting TWAS * These authors contributed equally † Correspondence to xwen@umich.edu results, especially regarding their causality implications. In this paper, we describe a new computational framework, probabilistic TWAS (PTWAS), to detect associations and investigate causal relationships between gene expression and complex traits. We use established concepts and principles from instrumental variables (IV) analysis to delineate and address the unique challenges that arise in TWAS. PTWAS utilizes probabilistic eQTL annotations derived from multi-variant Bayesian fine-mapping analysis conferring higher power to detect TWAS associations than existing methods. Additionally, PTWAS provides novel functionalities to evaluate the causal assumptions and estimate tissue-or cell-type specific causal effects of gene expression on complex traits. These features make PTWAS uniquely suited for in-depth investigations of the biological mechanisms that contribute to complex trait variation. Using eQTL data across 49 tissues from GTEx v8, we apply PTWAS to analyze 114 complex traits using GWAS summary statistics from several large-scale projects, including the UK Biobank. Our analysis reveals an abundance of genes with strong evidence of eQTL-mediated causal effects on complex traits and highlights the heterogeneity and tissue-relevance of these effects across complex traits. We distribute software and eQTL annotations to enable users performing rigorous TWAS analysis by leveraging the full potentials of the latest GTEx multi-tissue eQTL data.
Accurate estimation of causal effects
We further examine the estimation procedure by PTWAS and various TWAS methods using simulations. In this particular experiment, we focus on estimating the effects of genes that pass the initial PTWAS scan. It is important to note that our criteria to evaluate the estimation procedures differ from the hypothesis testing, and has a distinct focus on the estimation accuracy (e.g., measured by rooted mean square errors, or RMSE) on the gene-to-trait effects.
It might be intuitive to estimate the causal effect from a target gene to the complex trait of interest by simply regressing the complex trait phenotype on the composite IV or genetically predicted gene expression of the target gene. This approach, however, is not principled mainly because it ignores substantial uncertainty associated with the imputed gene expression levels.
In practice, such ad-hoc approach shows both noticeable bias and large variance in estimation ( Figure 3 ).
We evaluate the proposed effect estimation procedure and compare its performance to SMR, which implements a standard two-stage least square (2SLS) algorithm by utilizing the strongest eQTL SNP (form single-SNP analysis) as the sole instrument. In our simulation studies, both PTWAS and SMR yield seemingly unbiased estimates ( Figure 3 ). However, the results from PTWAS show higher accuracy. Even when a single (best) eQTL signal is utilized for estimation, we find that PTWAS is slightly more accurate (RMSE = 0.39) than SMR (RMSE = 0.44). This is likely due to the unique design of PTWAS that averages single-SNP estimates over a set of highly linked SNPs.
In all cases, we find that the estimation accuracy is directly correlated with the strength of instruments (i.e., eQTLs), which is quantified by the corresponding signal-level PIPs (Figure 4 ). By employing stronger eQTLs into the PTWAS estimation procedure, the accuracy monotonically increases. This observation directly verifies the estimation principle from the IV analysis. For a given SPIP threshold, we find that the estimates by combining multiple independent eQTLs For a closer inspection, we examine the joint analyses of GWAS data of CAD from the CARDiO-GRAM consortium and the GTEx eQTL data from whole blood. Figure 10 shows the scatter plot of the colocalization probabilities from ENLOC and the p-values from PTWAS. The plot displays a clear linear trend with high probabilities of colocalization corresponding to significant PTWAS p-values. However, the correlation is imperfect, as some most significant TWAS genes only exhibit weak evidence of colocalization, which is likely due to the differences of LD patterns in the GWAS and eQTL data for the relevant genomic regions.
Discussion
In this paper, we propose a new computational framework to systematically investigate potential causal mechanisms from tens of thousands of candidate molecular phenotypes leading to complex diseases.
TWAS presents some unique challenges for the traditional causal inference methodologies like the IV analysis. Notably, the large number of candidate genes is rarely encountered in the application scenarios from econometrics and epidemiology. This unique feature prompts developing efficient multiple hypothesis testing procedures to screen candidate genes effectively. It is equally important to note that hypothesis testing may not be the endpoint of a sound causal inference:
interpreting and validating the scan results have essential implications on follow-up studies. In this paper, we also illustrate that robust estimation of the causal effect, which has been emphasized in the traditional IV analysis, is critical to uncovering the impacts of cellular environments on disease etiology. Thus, we conclude that all three aspects of the PTWAS analysis: multiple hypothesis testing, model validation, and causal effect estimation, should be an integral part of causal inference in TWAS.
In PTWAS, our statistical strategies vary for different stages of the analysis. As noted by many authors [26, 16] , although both hypothesis testing and causal effect estimation in the IV/MR analysis are operated based on the same set of casual assumptions, estimation procedures require additional parametric assumptions to formally define the casual effect (in PTWAS, we adopt the traditional definition of the causal effect via the linear structural equations embedded in the 2SLS method). Although it is possible to construct the test statistics based on the estimated gene-to-trait effects, we show that such test statistics tend to be underpowered compared to composite IV-based test statistics. (This is likely due to the overestimation of the corresponding standard errors.) The detailed discussion on this topic is outside the scope of this paper, and we will provide a full account in a follow-up technical article.
In this paper, we regard the commonly referred "genetic predictions of gene expressions" in the scan procedure as composite instrumental variables for investigating the causal relationships between candidate genes and the complex trait of interest. Although it is conceptually correct to interpret the composite IVs as genetic predictions of gene expression phenotype, we note that such predictions are generally inaccurate. The evidence here is two-fold: first, existing studies suggest the overall heritability of gene expressions, on average, is quite low [27] ; second, as shown by many genomic experiments of differential gene expression analysis, manipulation of cellular environments can have drastic impacts on gene expression levels.
One of the advantages of the proposed PTWAS framework is its utilization of multiple independent eQTLs throughout the three stages of the analysis. This has been shown to improve the power of multiple hypothesis testing, enable the model validation, and increase the estimation efficiency. Importantly, our computational approaches carefully distinguish SNPs representing different independent eQTL signals and SNPs tagging the same eQTL signal. We note that regarding highly correlated SNPs as independent instruments are theoretically invalid. Instead, our approach uses a set of eQTL SNPs in LD (i.e., a Bayesian credible set) to represent an instrument and weight the evidence from individual SNPs through Bayesian model averaging (BMA). This strategy is proven effective in our simulations and real data analysis by carrying over the SNP-level uncertainty from the eQTL analysis. Recently, [28] propose an IV analysis approach, TWMR, to utilize multiple independent eQTLs identified from conditional analysis for estimating gene-to-trait effects in TWAS. Many authors have reported Bayesian multi-SNP fine-mapping methods, e.g., DAP, are more powerful than conditional analysis-based methods to effectively identify independent eQTLs [29, 30, 11] . Furthermore, TWMR estimation can be viewed as a special case of the proposed BMA weighting in PTWAS, which assigns all weights to the lead eQTL SNP within each signal cluster. However, such extreme weighting scheme seems sub-optimal in estimation accuracy as shown in our simulation studies.
Recently emerged TWAS methods, represented by FOCUS [31] and TWMR [28] , also consider the strong correlations among the observed expressions of multiple genes. In the extreme cases, if the expressions of two genes are perfectly correlated, the true causal gene is not identifiable.
Analyzing one gene at a time can fail to account for such correlations and result in over-reporting of causal genes. We have not explicitly addressed this issue in this paper due to our limited scope.
However, we note the test statistics/p-values derived from our novel PTWAS scan procedure can be directly plugged into the fine-mapping methods implemented in FOCUS and yield desired credible sets of causal genes. We will continuously pursue this direction in our follow-up work.
Finally, we acknowledge that, like any observational data based causal inference approach, the proposed procedure is imperfect. It is mainly because some critical causal assumptions can not be rigorously verified, and some required conditions are not satisfied for every gene-trait pair in practice. In our application context, a good proportion of genes lack discoveries of multiple independent and strong eQTLs. Thus, the proposed model validation procedure is not applicable. The emergence of large-scale eQTL datasets will alleviate this problem in the near future as the ability to uncover multiple eQTLs is directly correlated with the sample size of eQTL [9] . Nevertheless, from a theoretical point of view, only severe violations of causal assumptions can be detected by model diagnosis approaches. In other words, passing the model validation procedure does not prove the assumptions are true but only indicate that they are reasonable given the data at hand. Should such caveat deter our efforts to apply the proposed approaches, or more generally, formulate and perform observational-data based causal inference in TWAS?
Our opinion is no. The challenge is not unique to the field of genetics and genomics. We believe that our proposed approach falls into the category of "shoe leather" methodology advocated by David Freedman [32] , which "exploits natural variation to mitigate confounding and relies on intimate knowledge of the subject matter to develop meticulous research designs and eliminate rival explanations."
Methods
The probabilistic annotations of eQTLs used by PTWAS require comprehensive characterizations of the strengths and uncertainty of the genetic associations of expression traits at different levels.
At the model level, each plausible association model (i.e., a combination of SNPs, denoted by M i ) is assessed by a posterior model probability, P M i . When multiple independent eQTLs coexist for a gene, the model including all relevant representing SNPs should have much higher posterior probability than the models including only single or incomplete eQTLs. A SNP-level PIP, p j , characterizes if a particular SNP j is a causal eQTL. In the presence of LD, causal eQTLs may not be statistically identifiable even if the evidence for the existence of an eQTL can be overwhelmingly strong [25] . Thus, we use the signal-level PIP to quantify the overall strength of an independent eQTL. Specifically for each potential eQTL signal k, we identify a set of SNPs in LD that represent the same association signal. The corresponding signal-level PIP is computed by q k = j∈S k p j . Thus, the comprehensive probabilistic annotations of eQTLs for a gene is given by {(M i , P M i )}, {(S k , q k )}, {p j } . All these information are used for different tasks in PTWAS. 20 
TWAS as IV analysis
The instrumental variable analysis can be represented by the graphical model in Supplementary   Figure S1 . There are three key assumptions to establish causal implications from the IV analysis.
In the context of TWAS, they can be characterized as: i) inclusion restriction: the selected instrument (G), i.e., genetic variants, must be associated with the expression of the target gene (X); ii) randomization assumption: the instrument is (marginally) independent of confounders (U ); and iii) exclusion restriction: the selected genetic variants affect the complex trait of interest (Y ) only through the target gene. Notably, the inclusion restriction (IR) requires the instruments are eQTLs, and the exclusion restriction (ER) explicitly excludes the possibility of (horizontal) pleiotropy. Under these causal assumptions, the evidence of the association between G and Y , i.e., G ⊥ ⊥ Y , is sufficient to reject the null hypothesis that states no causal link between the target gene and the complex trait of interest [33, 26, 16] .
The two-sample design refers to the setting that G, X, and Y are not taken from the same samples. Instead, the eQTL data (G x , X) and the GWAS data (G y , Y ) are measured from two sets of non-overlapping samples. The two-sample design has some important implications on the IV analysis, especially the estimation bias of causal effects introduced by the weak instruments (i.e., weak eQTLs). In a one-sample design, the weak instruments can cause severe type I errors in testing causal relationships, whereas in a two-sample design, the bias is always towards 0, therefore, results only in the loss of power but not inflation of type I errors.
The weighted sum of IVs, i.e., i w i G i , is itself a valid instrumental variable because it satisfies all three IV assumptions. It is often referred to as a composite IV or allele score in literature [14, 15] . For hypothesis testing purposes, the aggregation of independent instruments with modest strength has an intuitive appeal for improved power for testing. 21 
Composite IV for hypothesis testing
If the true causal eQTLs are known, the principled inference procedure in the IV analysis is the two-stage least squares (2SLS) method [16] . In the settings of the two-sample design, the first stage regression in the 2SLS finds the least-squares prediction of gene expressions using the eQTL data. The resulting prediction function is, by definition, a composite IV, where the weight for each individual genetic variant is the least square estimate of the corresponding genetic effect on the expression phenotype. In practice, even after the fine-mapping of eQTLs, there is substantial uncertainty regarding the number of independent eQTLs and the actual causal SNP for each eQTL. Selecting a single "best" association model from the eQTL data to perform the 2SLS procedure does not convey the uncertainty from the eQTL analysis, hence unlikely optimal. We propose a model averaging approach that utilizes the posterior model probabilities {P M i } to construct composite IVs based on the existing 2SLS procedure. For a set of L sparse candidate association models identified from the eQTL analysis, we fit each model M i by the least-square algorithm. We obtain an effect size estimate,β M i ,j , for each SNP j in model M i . (β M i ,j = 0 if SNP j / ∈ M i .) We then compute an overall weight for SNP j by averaging its estimated effects across all L candidate models, i.e.,
Finally, the proposed composite instrumental variable,x, is computed by:
wherex M i denotes the least squares prediction by the model M i . Therefore, the resulting composite IV can be naturally interpreted as an ensemble prediction of expression levels for the target gene (and eachx M i is known as a base prediction).
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The composite IV (2) constructed by PTWAS has some unique and desired properties for the causal inference. First, it naturally considers multiple independent eQTL signals. Second, the weighting scheme also accounts for LD. Third, the proposed procedure provides a principled way to weigh weak versus strong instruments by utilizing the posterior model probabilities.
For a complex trait data set where individual-level data are available, we computex for each sample by plugging in the corresponding genotype data into the equation (2) 
Estimating causal effects
We take a slightly different strategy to estimate the causal effects from a target gene to the trait of interest to ensure accuracy and robustness. Notably, we emphasize in obtaining effect size estimates from strong instruments, where we quantify the strength of an instrument by its corresponding signal-level PIP. The designed filtering of weak instruments is to avoid biased estimates. When multiple independent eQTLs are available, we aggregate the estimates from the individual eQTLs using a fixed-effect meta-analysis procedure.
The proposed estimating procedure starts with selecting strong eQTLs by thresholding on the corresponding signal-level PIPs. For a qualified eQTL signal with m member SNPs and signal probability q = m i=1 p i , we then re-normalize the SNP probabilities bỹ
which corresponds to the conditional probability of SNP i being a causal eQTL. Next, we obtain 23 an estimate of the causal effect,β xy,i and the corresponding variance σ 2 xy,i based on the summary statistics of SNP i using the standard 2SLS method (i.e., similar to SMR). Subsequently, by the law of total expectation, we combine the individual estimate from each member SNP weighted by its conditional causal probability, i.e.,
Similarly, by the law of total variance, we obtain
For each independent instrument/eQTL, the proposed estimator provides an intuitive and principled approach to fully account for LD.
Under the IV assumptions, each independent eQTL provides an independent estimate of the underlying causal effects. If the causal link from the target gene to the complex trait is indeed true, the multiple estimates from independent eQTLs are analogous to the multiple estimates from a meta-analysis, where the underlying true causal effect should be constant regardless of the instruments used for measurement. By this logic, it becomes natural to adopt a fixed-effect meta-analysis model to combine the individualβ xy using the inverse variance weighting (IVW) scheme.
Diagnosis of exclusion restriction
The causality implications inferred from TWAS analysis are subject to the validity of the IV assumptions, especially the exclusion restriction (ER 
where T represents the number of independent eQTLs used for effect estimation, and Q is the Cochrans Q statistic and is given by
Specially, (β k ,σ k ) are estimated effect size and the corresponding standard error from the k-th independent eQTL, andβ is the fixed-effect estimate of the overall causal effect. The I 2 statistic ranges from 0 to 1 and is designed initially to represent the percentage of the variance observed in a meta-analysis that can be attributed to the heterogeneity among participating studies. In the application context of TWAS, I 2 → 0 indicates reasonable consistency among estimates by multiple eQTLs, whereas I 2 → 1 implies severe departures from ER.
We note that the underlying idea of the proposed model diagnosis approach is similar to the intuition behind Egger regression [8] that is widely applied in the context of MR analysis of multiple complex traits. However, the available independent eQTLs/instruments for any given gene are typically limited, which render the regression-type of diagnosis like Egger regression implausible. The proposed approach directly addresses this difficulty and is tailored for the application in TWAS.
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We use I 2 as a quantitative metric to measure the effect size heterogeneity in a comprehensible scale. It is theoretically possible to set up a hypothesis testing procedure to select genes with consistent eQTL-level estimates. Note that in this case, the null hypothesis has to assert heterogeneity in the underlying effect sizes. We have not seen any successful applications of such hypothesis testing. In practice, some authors suggest setting up the null hypothesis as in the Cochran's Q test (which states all underlying effects are the same) and attempting to "accept" the null hypothesis. This, in our view, is a statistical mistake.
Simulation details
Throughout our simulation studies, we use the real genotype data from 706 whole blood samples of the GTEx v8 data to simulate expression and complex trait phenotype data. To mimic the twosample design, we randomly select 400 individuals and 1000 genes to simulate their expression data. The remaining 306 individuals are used to simulate complex trait data.
For each gene, we select 1,500 cis-SNPs and independently sample the causal eQTLs from a
Bernoulli distribution with the frequency = 0.002, Thus, on average, each gene has three causal eQTLs. The effect size of each causal gene is sampled from a Gaussian distribution with mean 0 and variance 0.5. We also add a polygenic background effect to all candidate SNPs, such that the heritability of the expression phenotype is roughly 50% (variations are due to the allele frequencies of the causal SNPs). More specifically, for individual i, the expression level for a candidate gene, x i , is simulated by
where g i,j represents the genotype of SNP j for the i-th individual, β j , α j represents the (strong) sparse genetic effect and the polygenic effect, respectively, and γ j is the latent Bernoulli random 26 variable. The corresponding complex trait for individual i, y i , is subsequently simulated by a simple structural equation,
where η represents the causal gene-to-trait effects. To investigate the power and type I error control of the PTWAS scan procedure, we sample η from a Gaussian distribution N (0, φ 2 k ) where the variance parameter is chosen from the set {φ 2 k : 0, 0.2, 0.5, 0.8, 1, 1.2}. (Note that φ 2 k = 0 represents the null model). To examine the effect size estimation, we fix η = 1 for all simulated data sets. We simulate the expression data for all 706 individuals but use only the subset of 400 individuals for eQTL analysis. We only simulate the complex trait data for the subset of 306 individuals.
For the proposed PTWAS procedure, we analyze the eQTL data and construct the composite IVs using the software package DAP. For PrediXcan method, we apply the elastic net algorithm with cross-validation to find the genetic predictions of gene expressions. We also run the software package BSLMM to produce the predicted gene expression functions for TWAS-Fusion. When running the BSLMM, we apply the default settings except resetting the number of sampling steps to 200,000 and the burn-in steps to 100,000 for computational considerations.
Multi-tissue TWAS analysis
For multi-tissue TWAS analysis, we utilize the GTEx cis-eQTL data from 49 tissues (version 8) and 114 complex traits from the UK Biobank and other consortia. We perform multi-SNP fine-mapping of cis-eQTL analysis for each GTEx tissue using DAP, and generate the all three required levels of probabilistic annotations (i.e., posterior model probabilities, SNP-level PIPs, and signal-level PIPs) for the proposed PTWAS analysis. 27
Data preparation
The 114 complex trait data sets are selected and harmonized by the GTEx GWAS analysis subgroup. For each complex trait, only summary statistics are extracted, and additional summary statistics are imputed for the GTEx SNPs that are not directly available from the original studies.
The details of the GWAS data processing are documented in [20] .
The probabilistic eQTL annotations required by PTWAS are derived from the GTEx release v8 data across 49 tissues using DAP [11, 12] . The pre-processing of the RNA-seq and genotype data follow the protocols of the GTEx data processing, which are detailed in [9] . The multi-SNP fine-mapping analysis by DAP uses the individual-level genotype data and controls the same set of covariates and PEER factors as in GTEx v8 single-SNP eQTL mapping.
Multi-tissue PTWAS scan
Let β i xy denotes the unobserved causal effect from gene x to trait y in the i-th tissue. We apply a multi-tissue PTWAS scan to test a global null hypothesis that states β 1 xy = · · · = β L xy = 0.
To carry out the testing procedure, we first derive a p-value, p i xy , by applying the PTWAS scan procedure in the i-th tissue for the target gene-trait pair. We then apply the ACAT method [21] to the set of p-values for each gene-trait pair, {p i xy : 1, ..., 49}, and compute a p-value for testing the global null hypothesis. For each trait, we finally apply Storey's q-value procedure to control the false discovery rate at 5% level and identify the genes that reject the global null hypothesis. 28
Estimating gene-to-trait effects
For each complex trait, we focus on the set of genes implicated from the PTWAS scan procedure.
For a gene rejected at the scan stage (at FDR 5% level) for the trait of interest, we consider all its gene-tissue pairs (not just the most significant tissue) for the effect estimation and the model validation. We then select the gene-tissue-trait combination that contain at least one eQTL signal cluster with SPIP ≥ 0.50 for estimation purpose. This particular threshold is mainly informed by our simulation studies, where we observe reliable estimation results for signals with SPIP ≥ 0.50. To validate ER assumption, we require the selected gene-tissue-trait combinations to have more than two eQTL signal clusters with SPIP ≥ 0.50.
For each selected gene-tissue-trait combination, we carry out the proposed effect estimation and/or model validation procedures separately.
Software and data resources
The Github repository https://github.com/xqwen/ptwas/ contains the implementations of the algorithms described in this paper. The repository also provides a step-by-step guidelines on running the complete PTWAS analysis. The probabilistic annotations of eQTLs are generated by the software package DAP (https://github.com/xqwen/dap/) with both C++ and R implementations.
We have made the following resources available. 



